Mediplantex National Pharmaceutical JSC (HNX:MED)

HNX:MED Revenue

Mediplantex National Pharmaceutical JSC had revenue of 106.02B VND in the quarter ending September 30, 2026, with 21.67% growth. This brings the company's total for the last twelve months to 434.97B, up 22.39% year-over-year. In the year 2025, Mediplantex National Pharmaceutical JSC had annual revenue of 366.83B, down -17.22%. That makes Mediplantex National Pharmaceutical JSC the 34,805th largest company in the world by revenue and 485th in Vietnam.

• Revenue (ttm): 434.97B
• Revenue Growth: +22.39%
• P/S Ratio: 0.52
• Revenue / Employee: 1.40B
• Employees: 310
• Market Cap: 228.34B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	366.83B	-76.31B	-17.22%
Jan 1, 2025	443.14B	40.39B	10.03%
Jan 1, 2024	402.74B	1.69B	0.42%
Dec 31, 2022	401.05B	57.10B	16.60%
Dec 31, 2021	343.95B	-177.44B	-34.03%

Data Source: S&P Global Market Intelligence Last updated: Oct 19, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 1, 2026

Data Sources Report a data error